Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Rebold

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Open Forum Infectious Diseases|December 13, 2021
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative InfectionsNicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|July 14, 2021
Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant <i>Staphylococcus aureus</i> Bacteremia: STAPH StudySara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Infectious Diseases and Therapy|March 1, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational StudyNicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, et al.
Open Forum Infectious Diseases|April 11, 2025
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort StudyKaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-TazobactamSara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Open Forum Infectious Diseases|December 13, 2021
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative InfectionsNicholas Rebold, Taylor Morrisette, Abdalhamid M Lagnf, et al.
Open Forum Infectious Diseases|July 14, 2021
Standardized Treatment and Assessment Pathway Improves Mortality in Adults With Methicillin-resistant <i>Staphylococcus aureus</i> Bacteremia: STAPH StudySara Alosaimy, Abdalhamid M Lagnf, Taylor Morrisette, et al.
Infectious Diseases and Therapy|March 1, 2024
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational StudyNicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, et al.
Open Forum Infectious Diseases|April 11, 2025
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort StudyKaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2022
Nephrotoxicity of Vancomycin in Combination With Beta-Lactam Agents: Ceftolozane-Tazobactam vs Piperacillin-TazobactamSara Alosaimy, Abdalhamid M Lagnf, Athena L V Hobbs, et al.
Pageof 2